Showing results (281-290 of 463) with videos related to
Sort By:
Pageof 47
Acta Anaesthesiologica Scandinavica|February 18, 2005
Requirements of propofol at different end-points without adjuvant and during two different steady infusions of remifentanilS T Mustola, G A Baer, P J Neuvonen, et al.Clinical Pharmacology and Therapeutics|May 1, 1985
Bumetanide kinetics in renal failureP J Pentikäinen, A Pasternack, E Lampainen, et al.European Journal of Clinical Pharmacology|May 20, 1998
The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicinJ T Backman, K T Kivistö, K T Olkkola, et al.Anesthesia and Analgesia|July 14, 1998
The effect of intravenous and oral fluconazole on the pharmacokinetics and pharmacodynamics of intravenous alfentanilV J Palkama, M H Isohanni, P J Neuvonen, et al.European Journal of Clinical Pharmacology|December 1, 1998
Effect of erythromycin and itraconazole on the pharmacokinetics of intravenous lignocaineM H Isohanni, P J Neuvonen, V J Palkama, et al.Anesthesiology|December 1, 1996
Effect of diltiazem on midazolam and alfentanil disposition in patients undergoing coronary artery bypass graftingJ Ahonen, K T Olkkola, M Salmenperä, et al.Clinical Pharmacology and Therapeutics|January 1, 1999
Tamoxifen and toremifene concentrations in plasma are greatly decreased by rifampinK T Kivistö, K Villikka, L Nyman, et al.Acta Medica Scandinavica|April 1, 1975
Acetylator phenotype and the antihypertensive response to hydralazineA J Jounela, M Pasanen, M J MattilaActa Medica Scandinavica|January 1, 1981
Polymorphic acetylator phenotype and systemic lupus erythematosusE Johansson, K K Mustakallio, M J MattilaPageof 47